In this record we display differences in the product quality and level of immune responses to live and inactivated influenza virus administered IM, and demonstrate that for live virus administered intranasally, IM vaccination with live virus induces powerful antibody aswell as CD8+ T cell responses, offering protection against concern having a heterosubtypic disease thereby

In this record we display differences in the product quality and level of immune responses to live and inactivated influenza virus administered IM,…

Read more

For NKG2DL masking, mice were treated in weekly intervals (up to 4 weeks posttransplant) with either a cocktail of anti-MICA/B and anti-ULBP1, -ULBP3, -ULBP4, and -ULBP5 Abs (see above) or NKG2Dscd7 or relevant settings, all administered subcutaneously at the site of tumor cell implants or tail vein injection

For NKG2DL masking, mice were treated in weekly intervals (up to 4 weeks posttransplant) with either a cocktail of anti-MICA/B and anti-ULBP1, -ULBP3,…

Read more